New Colon Cancer Study Findings Have Been Reported by Researchers at Nanjing University of Chinese Medicine (Exploring the pharmacological mechanism of Xianlian Jiedu decoction in the treatment of colorectal Cancer based on network...).
In: Cancer Weekly, 2023-12-05, S. 599-599
serialPeriodical
Zugriff:
A recent report from Nanjing University of Chinese Medicine discusses the pharmacological mechanism of Xianlian Jiedu Decoction (XLJDD) in the treatment of colorectal cancer (CRC). The study utilized network pharmacology, molecular docking, and in vitro and in vivo experiments to explore the targets and mechanism of XLJDD. The research identified 36 active components and 122 targets for XLJDD, with 19 core targets finally screened. In vitro experiments confirmed that XLJDD inhibited the proliferation of colorectal cancer cells, and in vivo experiments showed that XLJDD inhibited tumor progression in mice. The study concluded that XLJDD has potential efficacy in the treatment of CRC. [Extracted from the article]
Copyright of Cancer Weekly is the property of NewsRx and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
Titel: |
New Colon Cancer Study Findings Have Been Reported by Researchers at Nanjing University of Chinese Medicine (Exploring the pharmacological mechanism of Xianlian Jiedu decoction in the treatment of colorectal Cancer based on network...).
|
---|---|
Zeitschrift: | Cancer Weekly, 2023-12-05, S. 599-599 |
Veröffentlichung: | 2023 |
Medientyp: | serialPeriodical |
ISSN: | 1071-7218 (print) |
Schlagwort: |
|
Sonstiges: |
|